Norwegian Institute of Public Health
101
8
16
57
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
4.0%
4 terminated/withdrawn out of 101 trials
93.4%
+6.9% vs industry average
9%
9 trials in Phase 3/4
7%
4 of 57 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (101)
NORCCAP: Norwegian Colorectal Cancer Prevention Trial
Role: lead
Pilot Study of a National Screening Programme for Bowel Cancer in Norway
Role: lead
Mammography Screening With Artificial Intelligence (MASAI)
Role: collaborator
Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB
Role: lead
Optimizing Mastitis Identification and Treatment
Role: collaborator
Long-term Effects of Breast Cancer Treatment
Role: lead
Enabling Environments for Non-communicable Disease Risk Reduction in Ethiopia
Role: lead
PERsonalized Mammographic Screening in Norway
Role: lead
The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway
Role: lead
Artificial Intelligence in Mammography Screening in Norway
Role: lead
Classroom Air Purifiers for Reducing School Absence
Role: lead
Targeting Lifestyle to Improve Colorectal Cancer Screening
Role: lead
The Benefit of Repairing the Deltoid Ligament in Unstable Ankle Fractures
Role: collaborator
The Mother in Norway Study
Role: collaborator
Conversation With Family Doctor to Increase COVID-19 Vaccine Uptake
Role: lead
Trial of 2nd Booster Dose of COVID-19 Vaccine
Role: lead
Promoting Wellbeing: The Five Ways at School Intervention
Role: collaborator
ImmigrantScreen Telephone Reminder Trial in Colorectal Cancer Screening
Role: lead
Effects of the 5 Ways to Wellbeing Course Effects of the 5 Ways to Wellbeing Course
Role: lead
New Families- Innovation and Development of the Child Health Services in Oslo
Role: collaborator